General Information
Version
7.0
Revision date
2025-11-26
Product name
LALLZYME CUVEE BLANC
1.2.1 Relevant identified uses
Oenological use
Emergency telephone
+385 1 234 8342, +420 224 919 293, +420 224 915 402, +45 82 12 12 12, +372 7943 794, +358 800 147 111, +358 9 471 977, +33 1 45 42 59 59, +49 (0) 30 19240, +30 21 07 79 37 77, +36 80 20 11 99, +36 1 476 6464, +354 543 22 22, +354 543 10 00, +353 1 809 2566, +353 1 809 2166, 06 305 4343, +371 67 04 24 73, +370 (5) 236 20 52, +352 8002 5500, +356 2545 6508, +31 88 755 80 00, +47 22 59 13 00, +48 32 368 21 16, +48 538 81 99 61, +351 800 250 250, +40 21 599 23 00, +381 11 360 84 40, +421 2 54 77 41 66, +421 ...
Icons in SDS
Company Information
company name
Lallemand Denmark A/S
e-mail address of the competent person responsible for the Safety Data Sheet
scourdesses@lallemand.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Hazard pictograms
GHS08
Signal word
Danger
Contains
Polygalacturonase; Beta-glucosidase
Hazard statements
H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 - Avoid breathing dust, vapours. P284 - In case of inadequate ventilation wear respiratory protection. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P311 - If experiencing respiratory symptoms: Call a POISON CENTER, doctor. P501 - Dispose of contents and container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Respiratory sensitisation, Category 1 H334 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause allergy or asthma symptoms or breathing difficulties if inhaled.
